Literature DB >> 9511066

Minimal inhibitory concentrations and minimal bactericidal concentrations of quinupristin/dalfopristin against clinical isolates of Corynebacterium jeikeium and Listeria monocytogenes.

L S Moore1, B Schneider, W J Holloway.   

Abstract

Thirty clinical isolates of Listeria monocytogenes and 30 clinical isolates of Corynebacterium jeikeium were tested against quinupristin/dalfopristin by the NCCLS broth macrodilution technique for determination of MICs. MBC testing was also performed on the 60 isolates. Quinupristin/dalfopristin MIC90 values against L. monocytogenes and C. jeikeium were 1.6 mg/L and 0.2 mg/L, respectively. Quinupristin/dalfopristin was bacteriostatic against these organisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9511066     DOI: 10.1093/jac/39.suppl_1.67

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

Review 1.  Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.

Authors:  H M Lamb; D P Figgitt; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  In vitro activity of quinupristin and dalfopristin in combination and alone against coryneform bacteria.

Authors:  G Funke; R Troxler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

3.  In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.

Authors:  F Soriano; R Fernández-Roblas; R Calvo; G García-Calvo
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 4.  Streptogramins and their potential role in geriatric medicine.

Authors:  B M Lomaestro; L L Briceland
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.